The mu/delta opioid dual agonist SRI22141 demonstrates increased anti-nociceptive efficacy with decreased tolerance and dependence in neuropathic pain models

Wei Lei; S. Ananthan; J. M.  Streicher

The mu/delta opioid dual agonist SRI22141 demonstrates increased anti-nociceptive efficacy with decreased tolerance and dependence in neuropathic pain models

Wei Lei, S. Ananthan, J. M. Streicher

College of Pharmacy & Health Sciences

Research output: Contribution to conference › Abstract › peer-review

Original language	American English
State	Published - Jan 2018
Event	Drug Discovery and Development Mini- Symposium - University of Arizona, Tucson, United States Duration: Jan 1 2018 → …

Conference

Conference	Drug Discovery and Development Mini- Symposium
Country/Territory	United States
City	Tucson
Period	1/1/18 → …

Cite this

The mu/delta opioid dual agonist SRI22141 demonstrates increased anti-nociceptive efficacy with decreased tolerance and dependence in neuropathic pain models. / Lei, Wei; Ananthan, S.; Streicher, J. M. .
2018. Abstract from Drug Discovery and Development Mini- Symposium, Tucson, Arizona, United States.

Research output: Contribution to conference › Abstract › peer-review

@conference{860fa5f94b7441fa8eabc2a9c55f3244,

title = "The mu/delta opioid dual agonist SRI22141 demonstrates increased anti-nociceptive efficacy with decreased tolerance and dependence in neuropathic pain models",

author = "Wei Lei and S. Ananthan and Streicher, \{J. M.\}",

year = "2018",

month = jan,

language = "American English",

note = "Drug Discovery and Development Mini- Symposium ; Conference date: 01-01-2018",

}